SlideShare une entreprise Scribd logo
1  sur  7
Télécharger pour lire hors ligne
Intracerebral hemorrhage: non-hypertensive causes.
                                           C S Kase


                                         Stroke. 1986;17:590-595
                                       doi: 10.1161/01.STR.17.4.590
       Stroke is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231
                     Copyright © 1986 American Heart Association, Inc. All rights reserved.
                                Print ISSN: 0039-2499. Online ISSN: 1524-4628




The online version of this article, along with updated information and services, is located on the
                                       World Wide Web at:
                              http://stroke.ahajournals.org/content/17/4/590.citation




Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in
Stroke can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office.
Once the online version of the published article for which permission is being requested is located, click Request
Permissions in the middle column of the Web page under Services. Further information about this process is
available in the Permissions and Rights Question and Answer document.

Reprints: Information about reprints can be found online at:
http://www.lww.com/reprints

Subscriptions: Information about subscribing to Stroke is online at:
http://stroke.ahajournals.org//subscriptions/



                      Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
590



                                                  Progress Reviews

        Intracerebral Hemorrhage: Non-Hypertensive Causes
                                                      CARLOS S. KASE,     M.D.

SPONTANEOUS, non-traumatic intracerebral hemor-                      small and medium-size arteries of the cerebral hemi-
rhage (ICH) in the adult is most commonly secondary                   spheres. The arteries affected are preferentially located
to hypertensive cerebrovascular disease. In 70-90% of                in the superficial layers of the cerebral cortex and the
cases of spontaneous ICH, arterial hypertension is the               leptomeninges,6-7 cerebral amyloid angiopathy (CAA)
presumed cause.1 These hypertensive hemorrhages                      being virtually absent in the deep grey nuclei, where
show a predilection for certain anatomic locations: the              ICH of hypertensive origin predominates. CAA is a
basal ganglia (the putamen in particular), the subcorti-             condition restricted to the cerebral vasculature, since it
cal white matter, and the thalamus account for 35%,                  is not associated with systemic vascular amyloidosis,8
25%, and 20% of ICHs, respectively, whereas the                      and it is almost always of sporadic occurrence, al-
posterior fossa locations, the cerebellum and pons, are              though familial incidence has been documented in Ice-
responsible for only 10% and 5% of the cases.2 Irre-                 land9 and in the Netherlands.10 In these the condition is
spective of their anatomic locations, the common                     inherited as an autosomal dominant trait, and leads to
pathogenesis in these hemorrhages involves the hyper-                ICH early in life, especially in the Icelandic families,
tension-induced degeneration of the media of small                   in which the majority of the ICHs occurred in the third
(50-200 micra) arteries called "lypo-hyalinosis,"3 and/              and fourth decades. In a group of these patients it has
or the formation of "microaneurysms", both of which                  beenrecentlyshown that the basic abnormality appears
occur preferentially in perforating or small sub-cortical            to be in the metabolism of an alkaline microprotein
arteries, thus resulting in the characteristic anatomic              called "y-trace", which is found in abnormally low
distribution of hypertensive ICH.                                    concentrations in the CSF of these patients, as com-
   A significant number of cases of ICH are due to                   pared with controls." An abnormality in the catabo-
causes other than hypertension. The frequency of such                lism of this microprotein is thought to cause the vascu-
cases varies from 25% to 50% among series, and de-                   lar deposition of amyloid fibrils.
pends on the anatomic type of ICH being considered:                     The common sporadic variety of CAA typically af-
non-hypertensive mechanisms may account for as                       fects elderly individuals. Its incidence in autopsy se-
many as 55% of "lobar" ICH cases,4'3 while pontine                   ries increases with age, from a mere 8% in the seventh
hemorrhage is virtually always (90%) hypertensive,                   decade, to close to 60% in individuals older than 90.7
and the deep ganglionic (putaminal, thalamic) and                    An association with Alzheimer's disease has long been
cerebellar varieties occupy an intermediate position                 recognized, particularly in regards to a high frequency
(35%, 25%, and 38% being of non-hypertensive                         of some of its histopathologic features in brains of
mechanism, respectively). Among the many possible                    patients with CAA. In at least 50% ofreportedcases of
mechanisms of ICH not primarily related to hyperten-                 CAA, neuritic plaques have been documented, with a
sion, there are several that occur with high enough                  lower frequency of detection of neurofibrillary tan-
frequency to warrant separate discussion. These                      gles. The presence of clinical progressive dementia of
causes of ICH are related to special types of arterial               the Alzheimer type has been reported with differing
pathology, to the presence of brain tumors, or to the                frequency in various series, affecting from 10% to
use of medications, and include: cerebral amyloid an-                30% of the patients.6-12 Pathologically, CAA is charac-
giopathy, small vascular malformations, primary or                   terized by deposits of Congo-red positive material in
metastatic brain tumors, oral anticoagulants, and am-                the media and adventitia of cortical and leptomenin-
phetamines and a variety of other sympathomimetic                    geal arteries. These Congo-red stained vessels show
drugs.                                                               characteristic bi-refringence under polarized light, and
                                                                     also exhibit fluorescence with thioflavin T staining.
          Cerebral Amyloid Angiopathy                                Electron microscopic studies demonstrate the typical
  This condition is a unique form of angiopathy due to               non-ramified 90-110 A diameter amyloid fibrils with-
deposits of amyloid in the media and adventitia of                   in the vessel wall. These lesions often lead to thicken-
                                                                     ing of the vascular wall, with stenosis or obstruction of
                                                                     the lumen,resultingin small foci of necrosis (infarcts),
                                                                     which are rarely if ever symptomatic. The only consis-
  From the Department of Neurology, Boston University School of
MediciDe, Boston, Massachusetts.                                     tent clinical result of CAA is ICH following rupture of
  Address correspondence to: Carlos S. Kase, M.D., Department of     an affected artery, due to either "weakening" of the
Neurology, Boston University School of Medicine, 720 Harrison Ave-   wall by the amyloid deposits, or to rupture of a secon-
nue, Suite 604, Boston, Massachusetts 02118.                         dary "microaneurysm" developed at sites of amyloid
  Received September 10, 1985; revision #1 accepted December 24,     deposition.6'l2
1985.




                            Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
INTRACEREBRAL HEMORRHAGE: NON-HYPERTENSIVE CAUSES/Kase                                         591

   The ICHs from CAA characteristically occur in su-            hematoma. The histologic type of vascular malforma-
perficial, subcortical or "lobar" locations, since the          tions leading to ICH most frequently corresponds to
angiopathy selectively affects arteries of the cortical         AVMs or venous angiomas, the cavernous angioma
surface and leptomeninges. Furthermore, these sub-              variety being rarely associated with bleeding. AVMs
cortical ICHs have shown, in some series, a predilec-           usually become symptomatic at a relatively early age,
tion for the posterior aspects of the cerebral hemi-            most commonly in the third and fourth decades, thus
spheres,reflectinga generally heavier concentration of          representing a potential source of ICH in non-hyper-
CAA-affected arteries in the parietal and occipital             tensive young populations.l8 A striking female prepon-
lobes.6'13 In some instances, subarachnoid or subdural          derance of these small vascular malformations has
hemorrhages have coexisted, again reflecting the su-            been reported in several series.17'l8
perficial location of the vascular lesions. An additional          Their clinical presentation is that of ICH in any
feature of ICH related to CAA has been a tendency to            location, deep or superficial, without specific clinical
producerecurrenthemorrhages over periods of months              features, other than perhaps a relatively slower course
or years,14 occasionally even leading to simultaneous           of development, as compared with the more abrupt and
acute intracerebral hematomas in two different brain            rapidly evolving course of hypertensive ICH. The
locations. In a number of published reports a history of        hemorrhages produced by these lesions tend to be more
head trauma or, less commonly, a prior neurosurgical            often at the level of the cerebral convexity (subcortical
procedure has preceded the onset of CAA-related ICH.            white matter) than in the deep portions of the hemi-
This raises the possibility that some of these hemor-           sphere, reflecting their usually more superficial loca-
rhages may be related to trauma, and the potential for          tion, a feature also documented for non-ruptured small
such complication should be recognized when a neuro-            cerebral vascular malformations incidentally found at
surgical procedure (such as ventricular shunt insertion,        autopsy. Due to their small size, the usual absence of
brain biopsy) is indicated for elderly demented pa-             symptoms prior to the onset of ICH, and the difficulty
tients. Furthermore, the need for meticulous hemosta-           in diagnosing them in life, these malformations have
sis following surgical evacuation of ICHs in the elderly        been called "cryptic" by some authors.16 On occasions
cannot be overemphasized. Some authors12 have con-              there is a family history of such vascular malforma-
sidered ICH from CAA a condition with poor vital                tions and ICH," but they occur more commonly on a
prognosis, on account of a generally larger size of the         sporadic basis. Since their documentation can result in
hemorrhages, and their tendency to recur. It is possible        successful surgical therapy and prevention of recurrent
that systematic search for this etiology in specimens           ICH, angiography should be considered part of the
from surgically-evacuated intracerebral hematomas               routine evaluation of non-hypertensive patients pre-
will provide an accurate estimate of the true frequency         senting with spontaneous ICH, in particular if the hem-
of CAA in cases of spontaneous ICH. Only then will              orrhage is located in the subcortical white matter of a
its prognosis and tendency to post-operative local re-          cerebral hemisphere. In a number of instances, pre-
currence be documented.                                         operative angiography has failed to document a vas-
   In conclusion, CAA is probably an important etiolo-          cular malformation that was diagnosed histologically
gic factor for ICH in non-hypertensive elderly individ-         following surgical evacuation of an intracerebral he-
uals who present with single or recurrent hemorrhages           matoma. l 7 '" These patients have usually had small
of subcortical "lobar" location. The actual frequency           AVMs or venous angiomas. The difficulties in demon-
of this disorder is unknown, but is probably quite high         strating the latter lesion angiographically probably
in elderly populations." It is expected that increased          stem from their small size and lack of multiple tortuous
awareness of this condition will lead to more accurate          vascular channels, as well as the absence of arterioven-
estimates of its frequency in surgical and autopsy              ous shunting of blood leading to marked dilatation of
specimens, and this effort may eventually result in             venous structures. In the case of small AVMs, lack of
effective measures for its treatment and prevention.            angiographic demonstration may at times reflect com-
                                                                pression by an adjacent hematoma, since repeat angio-
                                                                grams following resorption of the hematoma have oc-
           Small Vascular Malformations                         casionally disclosed mem. Spontaneous thrombosis
   These correspond to previously unsuspected small             may be an additional reason for lack of angiographic
intracerebral arteriovenous malformations (AVMs),               visualization of malformations. Due to the potentially
cavernous angiomas, or venous angiomas, that present            negative angiograms in the setting of an acute ICH due
as spontaneous ICH in adult life. Their reported fre-           to one of these malformations, some authors have rec-
quency in series of ICH has varied between 4 and 8%             ommended surgical evacuation of intracerebral hema-
of the cases.16' " The diagnosis is usually established         tomas in young non-hypertensive patients,17 since the
by cerebral angiography or, more commonly, follow-              resection of this type of lesion will likely prevent ICH
ing histologic study of biopsy specimens taken at the           recurrence.
time of surgical evacuation of the ICH. With the intro-
duction of CT scanning, an increasing number of these
lesions are being diagnosed by the demonstration of                               Brain Tumors
calcium deposits in their vicinity or, more commonly,             Hemorrhage into a brain tumor is a relatively rare,
by the post-contrast opacification of abnormal serpigi-         but well documented, cause of non-traumatic, non-
nous vascular channels adjacent to an intracerebral             hypertensive ICH. In series of brain tumors, ICH oc-



                        Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
592                                                      STROKE                         VOL 17, No 4, JULY-AUGUST    1986


curs in less than 1% of these cases, whereas underlying          acute effects of the ICH leading to uncal herniation and
tumors in ICH series are found in 2 to 6% of the                 brainstem compression or, less commonly, to the pro-
cases,2021 occasionally in as many as 10% of the                 gression of the underlying malignant tumor.23
cases.22 These are instances of ICH in either a pre-
viously unknown cerebral neoplasm or, more com-                                    Oral Anticoagulants
monly, as a complication of a known brain tumor. As a               Warfarin sodium, a widely used oral anticoagulant
result, ICH produces the acute onset of either a new             for the prevention of venous and arterial origin embo-
focal neurologic deficit, or worsening of pre-existing           lism, is associated with bleeding complications in ap-
focal deficits, in both instances commonly associated            proximately 7-8% of patients.2*-27 Intracranial hem-
with deterioration in the level of consciousness. The            orrhage accounts for a small fraction of these
brain tumors likely to present as ICH are largely malig-         hemorrhages, amounting to only 0.5-1.5% of all
nant, either primary astrocytoma (glioblastoma multi-            bleeding events related to warfarin. However, these
forme) or metastatic, most commonly bronchogenic                 intracranial hemorrhages have a generally dismal
carcinoma, melanoma, choriocarcinoma, or renal-cell              prognosis, thus resulting in a significant contribution
carcinoma.2124 Benign brain tumors such as meningio-             to the fatal complications of oral anticoagulant
mas or oligodendrogliomas have rarely been reported              therapy.
as presenting with episodes of non-traumatic ICH. The               The common intracranial sites of bleeding in orally
bleeding potential of malignant tumors is thought to be          anticoagulated patients are, in decreasing order of fre-
related to their tendency toward spontaneous necrosis            quency, the subdural space, brain parenchyma, and
and to the richness and neoplastic character of their            subarachnoid space. ICH in this setting represents a
vasculature, as well as the biologic tendency of some            condition with some distinct clinical characteristics
tumors such as choriocarcinoma to invade the walls of            and course, as well as high mortality and serious long-
blood vessels. Metastases from this tumor are note-              term sequelae in survivors. Oral anticoagulation has
worthy for their tendency to become hemorrhagic in at            been estimated to increase between 8-fold28 and 11-
least 50% of the cases.24                                        fold29 the risk of ICH, as compared with non-anti-
   The sites of ICH relate in some degree to the type of         coagulated individuals with similar risk factors for
underlying tumor, since deeply-seated white matter               intracranial hemorrhage. A number of possibly con-
tumors such as glioblastoma multiforme will produce              tributing factors to ICH have been suggested in this
deep hemispheric hemorrhages, while those resulting              patient population: A) Age. Several studies have indi-
from metastatic tumors are more often cortico-subcor-            cated a low frequency of ICH in patients younger than
tical, reflecting the predilection of secondary tumors           50, and an increased risk for ICH as a function of
for the superficial portions of the cerebral hemi-               increasing age,29 some suggesting age 65 as a point of
spheres. Most commonly, these hemorrhages originate              sharp rise in the risk.28 Although other series have
at the margins of the tumor, or between the tumor and            failed to show a clear relationship between increasing
the adjacent edematous brain parenchyma.21 Instances             age and higher risk of bleeding in anticoagulated pa-
in which an underlying tumor is suspected in a patient           tients,2* we believe that this form of therapy should be
with ICH include: (a) History of preceding chronic               given to patients who are older than 70 years of age
headache and/or focal neurologic deficit and/or per-             only after close scrutiny of its indications and the
sonality change for days or weeks prior to the onset of          subject's ability to comply with its proper use and
ICH, or the finding of papilledema on initial presenta-          monitoring. B) Hypertension. The contribution of this
tion with ICH; (b) The presence of multiple separated            factor to warfarin-related ICH has also been controver-
foci of ICH occurring simultaneously; (c) An area of             sial, some series strongly suggesting a relationship,29
"ring-like" hemorrhage with a low-density center in              while others have failed to document it.28 As a result,
non-contrast CT scan; (d) An ICH that on CT scan                 there are no defined guidelines for the indications or
appears as irregular, mottled high-density, and affect-          contraindications for oral anticoagulants in hyperten-
ing structures that are rarely involved in hypertensive          sives. It is our policy to exclude from chronic warfarin
ICH, such as the corpus callosum, which on the other             therapy patients who continue to have severe and labile
hand is frequently affected in glioblastoma multi-               hypertension in the face of full compliance with maxi-
forme; (e) A disproportionate degree of surrounding              mal anti-hypertensive therapy. C) Preceding cerebral
edema and mass effect associated with the hematoma;              infarction has been considered by some to be important
(f) Presence of post-contrast enhancement in the vi-             in the pathogenesis of anticoagulant-related ICH.30
cinities of the acute high-density ICH. An angiogram             However, recent large series29-3I have failed to support
can be useful in demonstrating a mass lesion with the            such an association: in a group of 24 patients with ICH
classical "tumor blush" characteristic of highly vascu-          in the course of warfarin therapy,31 only 1 bled into the
lar primary or metastatic brain tumors. In many in-              area of the brain that had 3 weeks before been affected
stances the diagnosis is only suspected by the finding           by an embolic infarct; all others with prior embolic
of clinical or radiologic signs of a systemic malignan-          infarcts (8 patients) had ICH in a vascular territory
cy, or it is established by biopsy of the hematoma               different from that involved previously. Although an
cavity following its surgical evacuation. The prognosis          embolic infarct can acutely become complicated by the
in this form of ICH is poor, with short-term (days to            formation of a hematoma in the setting of heparin or
weeks) mortality in the 90% range, mostly due to the             warfarin anticoagulation, this phenomenon is uncom-




                        Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
INTRACEREBRAL HEMORRHAGE: NON-HYPERTENSIVE CAVSES/Kase                                          593

mon, and appears to be limited to large size embolic             noted in one series,31 and that location was also over-
infarcts.32 D) Excessive prolongation of the prothrom-           represented in a group of 13 cases gathered from the
bin time. With very few exceptions,13 this factor is             literature.30-3739 This anatomical feature of warfarin-
considered to be a consistent feature in most hemorrha-          related hemorrhages has no clear explanation, as it is
gic complications in orally anticoagulated patients.             also unclear what the actual pathogenesis of these hem-
ICH is no exception to this rule: fully 80% of patients          orrhages is, in terms of the size and type of the ruptured
with ICH have excessively prolonged prothrombin                  vessels leading to the hemorrhage. It is possible that
times (PT) at the onset of hemorrhage. One major                 these hemorrhages arerelatedto bleeding from vessels
difficulty in clearly establishing this fact from the lit-       different from thoseresponsiblefor hypertensive ICH.
erature is the lack of agreement on what the "therapeu-          Serial microscopic sections of pathologic specimens
tic" PT range is: some authors recommend a prolonga-             will be required to clarify these points.
tion of the PT to 1 Vi to 2Vi times control,28' "• M while          The overall prognosis in these ICHs is poor, with
others use strictly I1/- times control.233 In studies of         mortalities in the range of 65% of the cases.29'3I This
warfarin therapy for prevention of venous thromboem-             high mortality correlates with generally large size he-
bolism, there is evidence that a "low-dose" schedule of          matomas, probably reflecting the slow but eventually
warfarin (enough to prolong the PT to 1VA control) is            massive extravasation of blood into the parenchyma as
associated with equal protection, but significantly few-         a result of the drug-induced coagulation defect. De-
er bleeding complications, than a "conventional"                 spite the routine use of vitamin K and fresh frozen
schedule with PT prolonged to 1 Vi to 2 times control.36         plasma for the rapidreversalof the coagulation defect,
Similar comparisons of different schedules of oral anti-         neurologic deterioration and fatal outcome is the ex-
coagulation are not available for the prevention of arte-        pected course in two-thirds of the cases.
rial thromboembolism. However, extrapolation from
the venous thromboembolism data suggest that it is                         Use of Amphetamines and Other
prudent to recommend adherence to "conservative"                               Sympathomimetic Drugs
levels of warfarin anticoagulation, in the range of 1 Vi
times control, for the prevention of bleeding complica-            A number of examples of ICH secondary to the use
tions. E) Duration of anticoagulant treatment. This             and abuse of amphetamines and related drugs have
factor has not shown a clear association with risk of           been documented. The most commonly implicated
ICH, since in some series the duration of therapy has           preparation has been methamphetamine by the intrave-
most often (in 65% of the cases) exceeded 1 year,29             nous route,40 but examples of ICH following its intra-
while in others as many as 70% of the events occurred           nasal and oral use are also in record. Less frequently,
within the first year of treatment.31 In a group of 12          the responsible substances have been amphetamine
cases gathered from several reports, the cases were             and pseudoephedrine. ICH has generally occurred
evenly distributed below and above 1 year of therapy            shortly after use of the drug, within minutes to a few
when the ICH occurred.3037-39 F) Head trauma does               hours after exposure, and the affected individuals have
not appear to play a role in ICH in the setting of oral         been in general chronic users, although occasional ex-
anticoagulation: only 4 of 24 patients (16%) had a              amples have followed alleged first-time use. The ma-
preceding history of trauma in a series of anticoagu-           jority of the hematomas have been located in the sub-
lant-related ICH.31 In all 4 instances the traumatic epi-       cortical white matter of the cerebral hemispheres, only
sode was considered mild in nature, and was not asso-           occasional ones occurring at the level of the basal
ciated with loss of consciousness.                              ganglia.4142
                                                                   An association with transiently elevated blood pres-
   The clinical presentation of anticoagulant-related           sure has been noted in approximately 50% of the cases,
ICH has some distinctive features. A gradual and slow           and thisrepresentsa likely etiologic mechanism. How-
progression of the focal signs was recorded in 58% of           ever, angiographic changes suggestive of vasculitis
the cases in one series, and one-half of these pro-             ("arteritis") have also been documented, raising the
gressed over exceedingly long periods of time, of 24,           possibility of a drug-induced angiopathy as the etiolo-
48, and even 72 hours.31 In some instances, this slowly         gic factor.43 This view is further supported by the re-
progressive course could be correlated with CT-detect-          ported disappearance of such angiographic changes
ed increase in size of the ICH. This feature contrasts          following drug discontinuation or the use of steroids.
with the usual course of hypertensive ICH, in which             This angiopathy, also called "speed arteritis", is char-
such a protracted initial course is rarely observed, and        acterized angiographically by multiple focal areas of
coincident enlargement of the hematoma by CT occurs             stenosis or constriction of medium-size intracranial
exceptionally following admission (observed in only 2           arteries. Pathologic examination of these vessels has
of a personal consecutive series of 100 cases of ICH).          shown a necrotizing angiitis similar to periarteritis no-
This extended initial course suggests a process of slow         dosa characterized by fibrinoid degeneration and ne-
bleeding into the parenchyma, different from the usu-           crosis of the media and intima of medium-size and
ally catastrophic course in patients with hypertensive          small arteries and arterioles, associated with variable
ICH. An additional feature in anticoagulant-related             degrees of inflammatory leukocytic infiltration of the
hemorrhages has been an apparent difference in their            vessel walls. At a later, reparative phase of the angiop-
topographic distribution, as compared with hyperten-            athy, collagen replacement of muscular and elastic
sive ICH: a relative predilection for the cerebellum was        tissue can follow, at times resulting in the formation of



                        Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
594                                                              STROKE                            VOL 17, No 4, JULY-AUGUST 1986


aneurysmal dilatations of the arterial wall.43 These vas-               6. Okazaki H, Reagan TJ, Campbell RJ: Clinicopathologic studies of
cular changes are considered to be secondary to either                      primary cerebral amyloid angiopathy. Mayo Clin Proc 54: 22-31,
                                                                            1979
a direct "toxic" effect of the drug or a hypersensitivity               7. Vinters HV, Gilbert JJ: Cerebral amyloid angiopathy: Incidence
reaction to the drug or its vehicle. In a few isolated                      and complications in the aging brain II. The distribution of amyloid
instances, angiography has revealed a coincidental                          vascular changes. Stroke 14: 924-928, 1983
AVM or aneurysm as the source of hemorrhage, which                      8. Gilbert JJ, Vinters HV: Cerebral amyloid angiopathy: Incidence
has been parenchymatous or subarachnoid, respective-                        and complications in the aging brain I. Cerebral hemorrhage.
                                                                            Stroke 14: 915-923, 1983
ly.44' 45 In these instances, the apparent role of the drug             9. Gudmundsson G, Hallgrimsson J, Jonasson TA, Bjarnason O:
has been that of the precipitant rather than the actual                     Hereditary cerebral haemorrhage with amyloidosis. Brain 95:
cause of the hemorrhage.                                                    387^04, 1972
   The usual therapy for this variety of ICH has been                  10. Wattendorff AR, Bots GTAM, Went LN, Endtz LJ: Familial cere-
                                                                            bral amyloid angiopathy presenting as recurrent cerebral haemor-
the use of high-dose steroids, occasionally accom-                          rhage. J Neurol Sci 55: 121-135, 1982
panied by immunosuppressant drugs (cyclophospha-                       11. Grugg A, Jensson O, Gudmundsson G, Amason A, Lofberg H,
mide). The clinical picture has followed the expected                       Malm J: Abnormal metabolism of y-trace alkaline microprotein:
course of slow resolution of the intracerebral hemato-                      The basic defect in hereditary cerebral hemorrhage with amyloido-
                                                                            sis. New Engl J Med 311: 1547-1549, 1984
ma, and follow-up angiograms have often shown an
                                                                       12. Kalyan-Raman UP, Kalyan-Raman K: Cerebral amyloid angiop-
improvement or disappearance of the signs of vasculi-                       athy causing intracranial hemorrhage. Ann Neurol 16: 321-329,
tis, attesting to its reversible character.                                 1984
   Phenylpropanolamine, a structural analog of am-                     13. Tomonaga M: Cerebral amyloid angiopathy in the elderly. J Amer
phetamine contained in over-the-counter appetite con-                      Geriatr Soc 29: 151-157, 1981
                                                                      14. Finelli PF, Kessimian N, Bernstein PW: Cerebral amyloid angiop-
trol and decongestant preparations, has been associat-                      athy manifesting as recurrent intracerebral hemorrhage. Arch
ed with ICH in previously healthy individuals.46-w The                      Neurol 41: 330-333, 1984
hematomas have occasionally been multiple and si-                     15. Drury I, Whisnant JP, Garraway WM: Primary intracerebral hem-
multaneous,47 and a "vasculitic" picture like that seen                    orrhage: Impact of CT on incidence. Neurology 34: 653-657, 1984
                                                                      16. Crawford JV, Russell DS: Cryptic arteriovenous and venous ham-
in amphetamine-related hemorrhages has also been                           artomas of the brain. J Neurol Neurosurg Psychiat 19: 1-11, 1956
documented. **• **                                                    17. Steiger HJ, Tew JM: Hemorrhage and epilepsy in cryptic cerebro-
   Illicit drugs have occasionally been associated with                    vascular malformations. Arch Neurol 41: 722-724, 1984
episodes of ICH closely following their use. These                    18. Becker DH, Townsend JJ, Kramer RA, Newton TH: Occult cere-
include cocaine,49 and the combination Talwin-pyri-                        brovascular malformations. A series of 18 histologically verified
                                                                           cases with negative angiography. Brain 102: 249—287, 1979
benzamine ("T's and blues").30 These drugs have at                    19. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous
times resulted in the production of cerebral infarction                     System, Fourth edition, Williams and Wilkins Co., Baltimore, pp
instead of ICH, and both lesions are thought to be the                      116-145, 1977
result of an angiopathy due to the drug or some of its                20. Russell DS: The pathology of spontaneous intracTanial haemor-
                                                                           rhages. Proc Roy Soc Med 47: 689-693, 1954
vehicles.                                                             21. Little JR, Dial B, Bellanger G, Carpenter S: Brain hemorrhage
   In conclusion, this review of non-hypertensive                          from intracranial tumor. Stroke 10: 283-288, 1979
causes of ICH suggests that these various pathological                22. Scott M: Spontaneous intracerebral hematoma caused by cerebral
entities account for a significant number of cases of                      neoplasms. Report of eight verified cases. J Neurosurg 42:
ICH. It is possible that theirrelativecontribution to the                  338-342, 1975
                                                                      23. Mandybur TI: Intracranial hemorrhage caused by metastatic tu-
total group of ICH cases will even increase in the                         mors. Neurology 27: 650-655, 1977
future, as the frequency of the hypertensive form of                  24. Gildersleve N, Koo AH, McDonald CJ: Metastatic tumor present-
ICH is likely to continue to decline, reflecting im-                       ing as intracerebral hemorrhage. Radiology 124: 109-112, 1977
proved control of hypertension in the population at                   25. Bitoh S, Hasegawa H, Ohtsuki H, Obashi J, Fujiwara M, Sakurai
                                                                           M: Cerebral neoplasms initially presenting with massive intracere-
risk. It is hoped that increased awareness, as well as                     bral hemorrhage. Surg Neurol 22: 57-62, 1984
improved diagnostic methods, willresultin the clinical                26. Coon WW, Willis PW: Hemorrhagic complications of anticoagu-
diagnosis of these conditions, which are currently for                     lant therapy. Arch Int Med 133: 386-392, 1974
the most part diagnosed only pathologically. This im-                 27. Forfar JC: A 7-year analysis of haemorrhage in patients on long-
provement in diagnosis is likely to provide a better                       term anticoagulant treatment. Brit Heart J 42: 128-132, 1979
                                                                      28. Furlan AJ, Whisnant JP, Elveback LR: The decreasing incidence of
estimate of their true frequency in the ICH population.                    primary intracerebral hemorrhage: A population study. Ann Neurol
                                                                           5: 367-373, 1979
                         References                                   29. Wintzen AR, de Jonge H, Loeliger EA, Bots GTAM: The risk of
1. Mohr JP, Caplan LR, Melski JW, et al: The Harvard Cooperative           intracerebral hemorrhage during oral anticoagulant treatment: A
   Stroke Registry: A prospective registry. Neurology 28: 754-762,         population study. Ann Neurol 16: 553-558, 1984
   1978                                                               30. Lieberman A, Hass WK, Pinto R, et al: IntracTanial hemorrhage
2. Mohr JP, Kase CS, Adams RD: Cerebrovascular Disorders. In:              and infarction in anticoagulated patients with prosthetic heart
   Harrison's Principles of Internal Medicine, 10th edition, RG Pe-        valves. Stroke 9: 18-24, 1978
   tersdorf et al (Eds), Chapter 356, pp 2028-2060. McGraw-Hill,      31. Kase CS, Robinson RK, Stein RW et al: Anticoagulant-related
   New York, 1983                                                          intracerebral hemorrhage. Neurology 35: 943-948, 1985
3. Fisher CM: Pathological observations in hypertensive cerebral      32. Hart RG, Lockwood KI, Hakim AM et al: Immediate anticoagula-
   hemorrhage. J Neuropath Exper Neurol 30: 536-550, 1971                  tion of embolic stroke: Brain hemorrhage and management options.
4. Kase CS, Williams JP, Wyatt DA, Mohr JP: Lobar intracerebral            Stroke 15: 779-789, 1984
   hematomas: Clinical and CT analysis of 22 cases. Neurology 32:     33. Miale JB: Laboratory Medicine: Hematology, 5th ed, chap 17, p.
   1146-1150, 1982                                                         959. CV Mosby, St. Louis, 1977
5. RopperAH, Davis KR: Lobar cerebral hemorrhages: Acute clinical     34. Braunwald E: Heart Disease, 2nd ed, chap 32, p. 1087. WB
   syndromes in 26 cases. Ann Neurol 8: 141-147, 1980                      Saunders, Philadelphia, 1984




                            Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
THROMBOLYTIC THERAPY IN STROKE/^/ Zoppo et al                                                         595

35. Wessler S, Gitel SN: Warfarin: From bedside to bench. New Engl J     43. Citron BP, Halpern M, McCarron M, et al: Necrotizing angiitis
    Med 311: 645-652, 1984                                                   associated with drug abuse. New Engl J Med 283: 1003-1011,
36. HullR, HirshJ, Jay R.etah Different intensities of oral anticoagu-       1970
    lant therapy in the treatment of proximal-vein thrombosis. New       44. Lukes SA: Intracerebral hemorrhage from an arteriovenous malfor-
    Engl J Med 307: 1676-1681, 1982                                          mation after amphetamine injection. Arch Neurol 40: 60—61, 1983
37. Barron KD, Fergusson G: Intracranial hemorrhage as a complica-       45. Maticlc H, Anderson D, Brumlik J: Cerebral vasculitis associated
    tion of anticoagulant therapy. Neurology 9: 447-455, 1959                with oral amphetamine overdose. Arch Neurol 40: 253-254, 1983
                                                                         46. Fallis RJ, Fisher M: Cerebral vasculitis and hemorrhage associated
38. Iizuka J: Intracranial and inlraspinal haematomas associated with
                                                                             with phenylpropanolamine. Neurology 35: 405—407, 1985
    anticoagulant therapy. Neurochirurgia 1: 15-25, 1972
                                                                         47. Kikta DG, Devereaux MW, Chandar K: Intracranial hemorrhages
39. Snyder M, Renaudin J: Intracranial hemorrhage associated with            due to phenylpropanolamine. Stroke 16: 510-512, 1985
    anticoagulation therapy. Surg Neurol 7: 31-34, 1977                  48. Stoessl AJ, Young GB, Feasby TE: Intracerebral haemorrhage and
40. Delaney P, Estes M: Intracranial hemorrhage with amphetamine             angiographic beading following ingestion of catecholaminergics.
    use. Neurology 30: 1125-1128, 1980                                       Stroke 16: 734-736, 1985
41. Harrington H, Heller HA, Dawson D, Caplan L, Rumbaugh C:             49. Caplan LR, Hier DB, Banks G: Stroke and drug abuse. Current
    Intracerebral hemorrhage and oral amphetamine. Arch Neurol 40:           Concepts of Cerebrovascular Disease/Stroke 17: 9-14, 1982
    503-507, 1983                                                        50. Caplan LR, Thomas C, Banks G: Central nervous system compli-
42. Salanova V, Taubner R: Intracerebral haemorrhage and vasculitis          cations of addiction to "T's and blues". Neurology 32: 623-628,
    secondary to amphetamine use. Postgrad Med J 60:429-430, 1984            1982




  Thrombolytic Therapy in Stroke: Possibilities and Hazards
          GREGORY      J. DEL ZOPPO, M.D., HERMANN ZEUMER, M.D.,* AND LAURENCE A. HARKER, M.D.


AGENTS WHICH MEDIATE THE dissolution of                                  patients with various thrombolytic agents, and to
thrombi are receiving increasingly wide therapeutic                      weigh the relative risk of intracerebral hemorrhage in
application. Urokinase or streptokinase have been em-                    patients treated with fibrinolytic agents for stroke and
ployed in the treatment of acute thrombosis of coro-                     for other thrombotic disorders.
nary1"23 and selected peripheral arteries,15' 23~34 traumat-
ic internal carotid artery occlusion,35 as well as of                                  Mechanism of Thrombolysis
pulmonary embolism36"39 and peripheral deep venous                          Arterial thrombosis and thrombus extension involve
thrombosis.1340"39                                                       to varying degrees the processes of endothelial injury,
   The demonstration that acute stroke is typically an                   platelet aggregation and release, and thrombin genera-
atherothrombotic or thromboembolic process60"76 pro-                     tion. Thrombin-mediated fibrinogen cleavage results
vides a theoretical basis for the use of thrombolytic                    in fibrin formation which is required for thrombus sta-
therapy in the treatment of acute stroke. However,                       bilization.80 Thrombin-mediated fibrin formation oc-
because of the possibility that intracerebral hemor-                     curs in direct relation to platelet activation by several
rhage may develop during thrombolytic therapy, use of                    mechanisms. Platelets promote activation of the early
such agents in stroke treatment has generally been con-                  stages of intrinsic coagulation by a process that in-
traindicated. Nevertheless, limited recent experience                    volves a factor XI receptor and high molecular weight
indicates that careful infusion of thrombolytic agents                   kininogen.81 Also, factors V and VHI interact with
may lead to thrombus dissolution and clinical improve-                   platelet membrane phospholipids to facilitate the acti-
ment in selected patients presenting with acute                          vation of factor X to Xa and the conversion of pro-
stroke.77"79                                                             thrombin to thrombin.82 Platelet-bound thrombin-
   It is the purpose of this discussion to review the                    modified factor V (factor Va) serves as a high affinity
molecular basis for the thrombolytic state, clinical                     platelet receptor for factor Xa.83 Consequently, the rate
experience with systemic and local treatment of stroke                   of thrombin generation is accelerated 103 fold, provid-
                                                                         ing a potent positive feedback mechanism for initiation
   From The Roon Research Center for Cardiovascular Disease and
                                                                         of thrombin formation on the platelet surface, fibrin
Thrombosis, Department of Basic and Clinical Research, Scripps Clime     network formation in the thrombus, and indirectly,
and Research Foundation, 10666 North Torrey Pines Road, La Jolla,        fibrinolysis.
California U.S.A. 92037, and from the Abteilung: Neurologie/Neurora-        Thrombus dissolution is, in large part, mediated by
diologie, Rheinische — Westphalische Technische Hochschule, Aa-
chen, Pauwelsstrasse, D5100, Aachen, Federal Republic of Germany.*
                                                                         fibrinolysis localized within the thrombus.84"86 Fibrin
  This work was supported in part by research grant HL 31950 from the    (and fibrinogen) degradation is catalyzed by plasmin,
National institutes of Health.                                           the product of plasminogen activation.87 In the consoli-
  Address correspondence to: Gregory J. Del Zoppo, M.D., Roon            dating thrombus plasminogen binds to fibrin and to
Research Center for Cardiovascular Disease and Thrombosis, Depart-       platelets, allowing local release of plasmin within the
ment of Basic and Clinical Research, Scripps Clinic and Research
Foundation, 10666 North Torrey Pines Road, La Jolla, California          thrombus. The circulating plasminogen activators, tis-
U.S.A. 92037.                                                            sue plasminogen activator (tPA) and single chain uro-
  Received February 6, 1986; revision #1 accepted May 12, 1986.          kinase plasminogen activator (scuPA), catalyze plas-




                              Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012

Contenu connexe

Tendances

Infection as a risk factor of stroke
Infection as a risk factor of strokeInfection as a risk factor of stroke
Infection as a risk factor of strokeOsama Ragab
 
The central nervous system ii
The central nervous system iiThe central nervous system ii
The central nervous system iiraj kumar
 
A rare case of cardiac amyloidosis diagnosed by MRI
A rare case of cardiac amyloidosis diagnosed by MRIA rare case of cardiac amyloidosis diagnosed by MRI
A rare case of cardiac amyloidosis diagnosed by MRIPrasunDas31
 
Cardiac amyloidosis,Review.2017
Cardiac amyloidosis,Review.2017Cardiac amyloidosis,Review.2017
Cardiac amyloidosis,Review.2017Dr.Hasan Mahmud
 
Cerebral venous sinus thrombosis by aminu arzet
Cerebral venous sinus thrombosis by aminu arzetCerebral venous sinus thrombosis by aminu arzet
Cerebral venous sinus thrombosis by aminu arzetAminuArzet
 
Etiology of hemiplegia
Etiology of hemiplegiaEtiology of hemiplegia
Etiology of hemiplegiaAbino David
 
Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)
Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)
Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)Sameep Koshti
 
Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseasesDenis Katatwire
 
IMAGING IN CEREBRAL VENOUS THROMBOSIS
IMAGING IN CEREBRAL VENOUS THROMBOSIS IMAGING IN CEREBRAL VENOUS THROMBOSIS
IMAGING IN CEREBRAL VENOUS THROMBOSIS Shivshankar Badole
 
Vascular diseases of the Central Nervous Sysytem
Vascular diseases of the Central Nervous SysytemVascular diseases of the Central Nervous Sysytem
Vascular diseases of the Central Nervous SysytemKevin Tan
 
Stroke : Introduction, types and treatment.
Stroke : Introduction, types and treatment.Stroke : Introduction, types and treatment.
Stroke : Introduction, types and treatment.Obed Adams
 
Pathophysio
PathophysioPathophysio
Pathophysioayagil
 

Tendances (20)

Genetics of stroke
Genetics of strokeGenetics of stroke
Genetics of stroke
 
Central nervous system pathology
Central nervous system pathology Central nervous system pathology
Central nervous system pathology
 
Infection as a risk factor of stroke
Infection as a risk factor of strokeInfection as a risk factor of stroke
Infection as a risk factor of stroke
 
The central nervous system ii
The central nervous system iiThe central nervous system ii
The central nervous system ii
 
A rare case of cardiac amyloidosis diagnosed by MRI
A rare case of cardiac amyloidosis diagnosed by MRIA rare case of cardiac amyloidosis diagnosed by MRI
A rare case of cardiac amyloidosis diagnosed by MRI
 
ENDOMYOCARDIAL FIBROSIS
ENDOMYOCARDIAL FIBROSISENDOMYOCARDIAL FIBROSIS
ENDOMYOCARDIAL FIBROSIS
 
ARVD
ARVDARVD
ARVD
 
Cardiac amyloidosis,Review.2017
Cardiac amyloidosis,Review.2017Cardiac amyloidosis,Review.2017
Cardiac amyloidosis,Review.2017
 
Cerebral venous sinus thrombosis by aminu arzet
Cerebral venous sinus thrombosis by aminu arzetCerebral venous sinus thrombosis by aminu arzet
Cerebral venous sinus thrombosis by aminu arzet
 
Etiology of hemiplegia
Etiology of hemiplegiaEtiology of hemiplegia
Etiology of hemiplegia
 
0914
09140914
0914
 
Atherosclerosis 3
Atherosclerosis 3Atherosclerosis 3
Atherosclerosis 3
 
Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)
Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)
Aneurysm of brain - Dr Sameep Koshti (NeuroSurgeon)
 
Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseases
 
Cns
CnsCns
Cns
 
IMAGING IN CEREBRAL VENOUS THROMBOSIS
IMAGING IN CEREBRAL VENOUS THROMBOSIS IMAGING IN CEREBRAL VENOUS THROMBOSIS
IMAGING IN CEREBRAL VENOUS THROMBOSIS
 
stroke
 stroke stroke
stroke
 
Vascular diseases of the Central Nervous Sysytem
Vascular diseases of the Central Nervous SysytemVascular diseases of the Central Nervous Sysytem
Vascular diseases of the Central Nervous Sysytem
 
Stroke : Introduction, types and treatment.
Stroke : Introduction, types and treatment.Stroke : Introduction, types and treatment.
Stroke : Introduction, types and treatment.
 
Pathophysio
PathophysioPathophysio
Pathophysio
 

En vedette

Gestión directiva
Gestión directivaGestión directiva
Gestión directivaLuis Angel
 
Presentasi_DNG
Presentasi_DNGPresentasi_DNG
Presentasi_DNGdngsuper
 
Presentasi_DNG_October
Presentasi_DNG_OctoberPresentasi_DNG_October
Presentasi_DNG_Octoberdngsuper
 
慶聯港都強推 Universal頻道 介紹 20121019
慶聯港都強推 Universal頻道 介紹 20121019慶聯港都強推 Universal頻道 介紹 20121019
慶聯港都強推 Universal頻道 介紹 20121019CL14780
 
Presentasi DNGSUPER
Presentasi DNGSUPERPresentasi DNGSUPER
Presentasi DNGSUPERdngsuper
 
Presentas_New_DNGSUPER
Presentas_New_DNGSUPERPresentas_New_DNGSUPER
Presentas_New_DNGSUPERdngsuper
 
Presentation1
Presentation1Presentation1
Presentation117050379
 
Presentasi_DNG_October_2012
Presentasi_DNG_October_2012Presentasi_DNG_October_2012
Presentasi_DNG_October_2012dngsuper
 
Presentasi_DNG_Ver_October_2012
Presentasi_DNG_Ver_October_2012Presentasi_DNG_Ver_October_2012
Presentasi_DNG_Ver_October_2012dngsuper
 
Enjoy the process
Enjoy the processEnjoy the process
Enjoy the processCL14780
 
Presentasi_DNGSUPER_October_2012
Presentasi_DNGSUPER_October_2012Presentasi_DNGSUPER_October_2012
Presentasi_DNGSUPER_October_2012dngsuper
 
慶聯港都精選頻道艾美獎介紹 20121007
慶聯港都精選頻道艾美獎介紹 20121007慶聯港都精選頻道艾美獎介紹 20121007
慶聯港都精選頻道艾美獎介紹 20121007CL14780
 
Presentasi_DNG_December_2012
Presentasi_DNG_December_2012Presentasi_DNG_December_2012
Presentasi_DNG_December_2012dngsuper
 
A study on Mobile Banking on Bangladesh
A study on Mobile Banking on BangladeshA study on Mobile Banking on Bangladesh
A study on Mobile Banking on BangladeshAnthony Mazumder
 
Bermuda Triangle Mystery or Miracle
Bermuda Triangle Mystery or MiracleBermuda Triangle Mystery or Miracle
Bermuda Triangle Mystery or MiracleArchit Mohanty
 

En vedette (19)

Gestión directiva
Gestión directivaGestión directiva
Gestión directiva
 
Angelica
AngelicaAngelica
Angelica
 
Presentasi_DNG
Presentasi_DNGPresentasi_DNG
Presentasi_DNG
 
Presentasi_DNG_October
Presentasi_DNG_OctoberPresentasi_DNG_October
Presentasi_DNG_October
 
慶聯港都強推 Universal頻道 介紹 20121019
慶聯港都強推 Universal頻道 介紹 20121019慶聯港都強推 Universal頻道 介紹 20121019
慶聯港都強推 Universal頻道 介紹 20121019
 
Presentasi DNGSUPER
Presentasi DNGSUPERPresentasi DNGSUPER
Presentasi DNGSUPER
 
Presentas_New_DNGSUPER
Presentas_New_DNGSUPERPresentas_New_DNGSUPER
Presentas_New_DNGSUPER
 
Presentation1
Presentation1Presentation1
Presentation1
 
Presentasi_DNG_October_2012
Presentasi_DNG_October_2012Presentasi_DNG_October_2012
Presentasi_DNG_October_2012
 
Presentasi_DNG_Ver_October_2012
Presentasi_DNG_Ver_October_2012Presentasi_DNG_Ver_October_2012
Presentasi_DNG_Ver_October_2012
 
Enjoy the process
Enjoy the processEnjoy the process
Enjoy the process
 
Presentasi_DNGSUPER_October_2012
Presentasi_DNGSUPER_October_2012Presentasi_DNGSUPER_October_2012
Presentasi_DNGSUPER_October_2012
 
慶聯港都精選頻道艾美獎介紹 20121007
慶聯港都精選頻道艾美獎介紹 20121007慶聯港都精選頻道艾美獎介紹 20121007
慶聯港都精選頻道艾美獎介紹 20121007
 
Presentasi_DNG_December_2012
Presentasi_DNG_December_2012Presentasi_DNG_December_2012
Presentasi_DNG_December_2012
 
Pdhpe
PdhpePdhpe
Pdhpe
 
SWOT Analysis
SWOT AnalysisSWOT Analysis
SWOT Analysis
 
B kash
B kashB kash
B kash
 
A study on Mobile Banking on Bangladesh
A study on Mobile Banking on BangladeshA study on Mobile Banking on Bangladesh
A study on Mobile Banking on Bangladesh
 
Bermuda Triangle Mystery or Miracle
Bermuda Triangle Mystery or MiracleBermuda Triangle Mystery or Miracle
Bermuda Triangle Mystery or Miracle
 

Similaire à 590.full

Radiological pathology of spontaneous cerebral hemorrhage
Radiological pathology of spontaneous cerebral hemorrhageRadiological pathology of spontaneous cerebral hemorrhage
Radiological pathology of spontaneous cerebral hemorrhageProfessor Yasser Metwally
 
Radiological pathology of cerebral microbleeds
Radiological pathology of cerebral microbleedsRadiological pathology of cerebral microbleeds
Radiological pathology of cerebral microbleedsProfessor Yasser Metwally
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxNeurologyKota
 
Aneurysm
AneurysmAneurysm
Aneurysmasalim4
 
Sub-Arachnoid Hemorrhage
Sub-Arachnoid HemorrhageSub-Arachnoid Hemorrhage
Sub-Arachnoid Hemorrhagedrraajitchanana
 
Stroke localization symptoms ms 2019
Stroke localization symptoms ms 2019Stroke localization symptoms ms 2019
Stroke localization symptoms ms 2019cardilogy
 
Carotid endarterectomy
Carotid endarterectomyCarotid endarterectomy
Carotid endarterectomyLiew Boon Seng
 
cerebral vascular malformation
cerebral vascular malformationcerebral vascular malformation
cerebral vascular malformationMojtabaKhazaei2
 
Cerebrovascular diseases.pptx
Cerebrovascular diseases.pptxCerebrovascular diseases.pptx
Cerebrovascular diseases.pptxtesa10
 
Hypertensive hd, and cardiomyopathy 3
Hypertensive hd, and cardiomyopathy 3Hypertensive hd, and cardiomyopathy 3
Hypertensive hd, and cardiomyopathy 3Forensic Pathology
 
Small Vessel Disease
Small Vessel DiseaseSmall Vessel Disease
Small Vessel DiseaseAhmed Mohamed
 
Intracranial anurysm
Intracranial anurysmIntracranial anurysm
Intracranial anurysmEDWINjose43
 
SUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdfSUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdfShapi. MD
 
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptxintracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptxHASSENZAINABUKEMISA
 
stroke in pediatric population
stroke in pediatric populationstroke in pediatric population
stroke in pediatric populationNeurologyKota
 

Similaire à 590.full (20)

Radiological pathology of spontaneous cerebral hemorrhage
Radiological pathology of spontaneous cerebral hemorrhageRadiological pathology of spontaneous cerebral hemorrhage
Radiological pathology of spontaneous cerebral hemorrhage
 
Radiological pathology of cerebral microbleeds
Radiological pathology of cerebral microbleedsRadiological pathology of cerebral microbleeds
Radiological pathology of cerebral microbleeds
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
 
Document
DocumentDocument
Document
 
Aneurysm
AneurysmAneurysm
Aneurysm
 
Sub-Arachnoid Hemorrhage
Sub-Arachnoid HemorrhageSub-Arachnoid Hemorrhage
Sub-Arachnoid Hemorrhage
 
Stroke localization symptoms ms 2019
Stroke localization symptoms ms 2019Stroke localization symptoms ms 2019
Stroke localization symptoms ms 2019
 
Carotid endarterectomy
Carotid endarterectomyCarotid endarterectomy
Carotid endarterectomy
 
cerebral vascular malformation
cerebral vascular malformationcerebral vascular malformation
cerebral vascular malformation
 
Cerebrovascular diseases.pptx
Cerebrovascular diseases.pptxCerebrovascular diseases.pptx
Cerebrovascular diseases.pptx
 
Hypertensive hd, and cardiomyopathy 3
Hypertensive hd, and cardiomyopathy 3Hypertensive hd, and cardiomyopathy 3
Hypertensive hd, and cardiomyopathy 3
 
Small Vessel Disease
Small Vessel DiseaseSmall Vessel Disease
Small Vessel Disease
 
Intracranial anurysm
Intracranial anurysmIntracranial anurysm
Intracranial anurysm
 
SUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdfSUB-Arachnoid Haemorrhage.pdf
SUB-Arachnoid Haemorrhage.pdf
 
SAH by dr,swapna
SAH  by dr,swapnaSAH  by dr,swapna
SAH by dr,swapna
 
Acyanotic heart diseases
Acyanotic heart diseasesAcyanotic heart diseases
Acyanotic heart diseases
 
2. stroke
2. stroke  2. stroke
2. stroke
 
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptxintracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
intracranial hemorrhage- by KEMISA HASSEN ZAINABU IIHS_jinjaUGANDA (2).pptx
 
stroke in pediatric population
stroke in pediatric populationstroke in pediatric population
stroke in pediatric population
 
stroke
strokestroke
stroke
 

590.full

  • 1. Intracerebral hemorrhage: non-hypertensive causes. C S Kase Stroke. 1986;17:590-595 doi: 10.1161/01.STR.17.4.590 Stroke is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Copyright © 1986 American Heart Association, Inc. All rights reserved. Print ISSN: 0039-2499. Online ISSN: 1524-4628 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://stroke.ahajournals.org/content/17/4/590.citation Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Stroke can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: http://www.lww.com/reprints Subscriptions: Information about subscribing to Stroke is online at: http://stroke.ahajournals.org//subscriptions/ Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
  • 2. 590 Progress Reviews Intracerebral Hemorrhage: Non-Hypertensive Causes CARLOS S. KASE, M.D. SPONTANEOUS, non-traumatic intracerebral hemor- small and medium-size arteries of the cerebral hemi- rhage (ICH) in the adult is most commonly secondary spheres. The arteries affected are preferentially located to hypertensive cerebrovascular disease. In 70-90% of in the superficial layers of the cerebral cortex and the cases of spontaneous ICH, arterial hypertension is the leptomeninges,6-7 cerebral amyloid angiopathy (CAA) presumed cause.1 These hypertensive hemorrhages being virtually absent in the deep grey nuclei, where show a predilection for certain anatomic locations: the ICH of hypertensive origin predominates. CAA is a basal ganglia (the putamen in particular), the subcorti- condition restricted to the cerebral vasculature, since it cal white matter, and the thalamus account for 35%, is not associated with systemic vascular amyloidosis,8 25%, and 20% of ICHs, respectively, whereas the and it is almost always of sporadic occurrence, al- posterior fossa locations, the cerebellum and pons, are though familial incidence has been documented in Ice- responsible for only 10% and 5% of the cases.2 Irre- land9 and in the Netherlands.10 In these the condition is spective of their anatomic locations, the common inherited as an autosomal dominant trait, and leads to pathogenesis in these hemorrhages involves the hyper- ICH early in life, especially in the Icelandic families, tension-induced degeneration of the media of small in which the majority of the ICHs occurred in the third (50-200 micra) arteries called "lypo-hyalinosis,"3 and/ and fourth decades. In a group of these patients it has or the formation of "microaneurysms", both of which beenrecentlyshown that the basic abnormality appears occur preferentially in perforating or small sub-cortical to be in the metabolism of an alkaline microprotein arteries, thus resulting in the characteristic anatomic called "y-trace", which is found in abnormally low distribution of hypertensive ICH. concentrations in the CSF of these patients, as com- A significant number of cases of ICH are due to pared with controls." An abnormality in the catabo- causes other than hypertension. The frequency of such lism of this microprotein is thought to cause the vascu- cases varies from 25% to 50% among series, and de- lar deposition of amyloid fibrils. pends on the anatomic type of ICH being considered: The common sporadic variety of CAA typically af- non-hypertensive mechanisms may account for as fects elderly individuals. Its incidence in autopsy se- many as 55% of "lobar" ICH cases,4'3 while pontine ries increases with age, from a mere 8% in the seventh hemorrhage is virtually always (90%) hypertensive, decade, to close to 60% in individuals older than 90.7 and the deep ganglionic (putaminal, thalamic) and An association with Alzheimer's disease has long been cerebellar varieties occupy an intermediate position recognized, particularly in regards to a high frequency (35%, 25%, and 38% being of non-hypertensive of some of its histopathologic features in brains of mechanism, respectively). Among the many possible patients with CAA. In at least 50% ofreportedcases of mechanisms of ICH not primarily related to hyperten- CAA, neuritic plaques have been documented, with a sion, there are several that occur with high enough lower frequency of detection of neurofibrillary tan- frequency to warrant separate discussion. These gles. The presence of clinical progressive dementia of causes of ICH are related to special types of arterial the Alzheimer type has been reported with differing pathology, to the presence of brain tumors, or to the frequency in various series, affecting from 10% to use of medications, and include: cerebral amyloid an- 30% of the patients.6-12 Pathologically, CAA is charac- giopathy, small vascular malformations, primary or terized by deposits of Congo-red positive material in metastatic brain tumors, oral anticoagulants, and am- the media and adventitia of cortical and leptomenin- phetamines and a variety of other sympathomimetic geal arteries. These Congo-red stained vessels show drugs. characteristic bi-refringence under polarized light, and also exhibit fluorescence with thioflavin T staining. Cerebral Amyloid Angiopathy Electron microscopic studies demonstrate the typical This condition is a unique form of angiopathy due to non-ramified 90-110 A diameter amyloid fibrils with- deposits of amyloid in the media and adventitia of in the vessel wall. These lesions often lead to thicken- ing of the vascular wall, with stenosis or obstruction of the lumen,resultingin small foci of necrosis (infarcts), which are rarely if ever symptomatic. The only consis- From the Department of Neurology, Boston University School of MediciDe, Boston, Massachusetts. tent clinical result of CAA is ICH following rupture of Address correspondence to: Carlos S. Kase, M.D., Department of an affected artery, due to either "weakening" of the Neurology, Boston University School of Medicine, 720 Harrison Ave- wall by the amyloid deposits, or to rupture of a secon- nue, Suite 604, Boston, Massachusetts 02118. dary "microaneurysm" developed at sites of amyloid Received September 10, 1985; revision #1 accepted December 24, deposition.6'l2 1985. Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
  • 3. INTRACEREBRAL HEMORRHAGE: NON-HYPERTENSIVE CAUSES/Kase 591 The ICHs from CAA characteristically occur in su- hematoma. The histologic type of vascular malforma- perficial, subcortical or "lobar" locations, since the tions leading to ICH most frequently corresponds to angiopathy selectively affects arteries of the cortical AVMs or venous angiomas, the cavernous angioma surface and leptomeninges. Furthermore, these sub- variety being rarely associated with bleeding. AVMs cortical ICHs have shown, in some series, a predilec- usually become symptomatic at a relatively early age, tion for the posterior aspects of the cerebral hemi- most commonly in the third and fourth decades, thus spheres,reflectinga generally heavier concentration of representing a potential source of ICH in non-hyper- CAA-affected arteries in the parietal and occipital tensive young populations.l8 A striking female prepon- lobes.6'13 In some instances, subarachnoid or subdural derance of these small vascular malformations has hemorrhages have coexisted, again reflecting the su- been reported in several series.17'l8 perficial location of the vascular lesions. An additional Their clinical presentation is that of ICH in any feature of ICH related to CAA has been a tendency to location, deep or superficial, without specific clinical producerecurrenthemorrhages over periods of months features, other than perhaps a relatively slower course or years,14 occasionally even leading to simultaneous of development, as compared with the more abrupt and acute intracerebral hematomas in two different brain rapidly evolving course of hypertensive ICH. The locations. In a number of published reports a history of hemorrhages produced by these lesions tend to be more head trauma or, less commonly, a prior neurosurgical often at the level of the cerebral convexity (subcortical procedure has preceded the onset of CAA-related ICH. white matter) than in the deep portions of the hemi- This raises the possibility that some of these hemor- sphere, reflecting their usually more superficial loca- rhages may be related to trauma, and the potential for tion, a feature also documented for non-ruptured small such complication should be recognized when a neuro- cerebral vascular malformations incidentally found at surgical procedure (such as ventricular shunt insertion, autopsy. Due to their small size, the usual absence of brain biopsy) is indicated for elderly demented pa- symptoms prior to the onset of ICH, and the difficulty tients. Furthermore, the need for meticulous hemosta- in diagnosing them in life, these malformations have sis following surgical evacuation of ICHs in the elderly been called "cryptic" by some authors.16 On occasions cannot be overemphasized. Some authors12 have con- there is a family history of such vascular malforma- sidered ICH from CAA a condition with poor vital tions and ICH," but they occur more commonly on a prognosis, on account of a generally larger size of the sporadic basis. Since their documentation can result in hemorrhages, and their tendency to recur. It is possible successful surgical therapy and prevention of recurrent that systematic search for this etiology in specimens ICH, angiography should be considered part of the from surgically-evacuated intracerebral hematomas routine evaluation of non-hypertensive patients pre- will provide an accurate estimate of the true frequency senting with spontaneous ICH, in particular if the hem- of CAA in cases of spontaneous ICH. Only then will orrhage is located in the subcortical white matter of a its prognosis and tendency to post-operative local re- cerebral hemisphere. In a number of instances, pre- currence be documented. operative angiography has failed to document a vas- In conclusion, CAA is probably an important etiolo- cular malformation that was diagnosed histologically gic factor for ICH in non-hypertensive elderly individ- following surgical evacuation of an intracerebral he- uals who present with single or recurrent hemorrhages matoma. l 7 '" These patients have usually had small of subcortical "lobar" location. The actual frequency AVMs or venous angiomas. The difficulties in demon- of this disorder is unknown, but is probably quite high strating the latter lesion angiographically probably in elderly populations." It is expected that increased stem from their small size and lack of multiple tortuous awareness of this condition will lead to more accurate vascular channels, as well as the absence of arterioven- estimates of its frequency in surgical and autopsy ous shunting of blood leading to marked dilatation of specimens, and this effort may eventually result in venous structures. In the case of small AVMs, lack of effective measures for its treatment and prevention. angiographic demonstration may at times reflect com- pression by an adjacent hematoma, since repeat angio- grams following resorption of the hematoma have oc- Small Vascular Malformations casionally disclosed mem. Spontaneous thrombosis These correspond to previously unsuspected small may be an additional reason for lack of angiographic intracerebral arteriovenous malformations (AVMs), visualization of malformations. Due to the potentially cavernous angiomas, or venous angiomas, that present negative angiograms in the setting of an acute ICH due as spontaneous ICH in adult life. Their reported fre- to one of these malformations, some authors have rec- quency in series of ICH has varied between 4 and 8% ommended surgical evacuation of intracerebral hema- of the cases.16' " The diagnosis is usually established tomas in young non-hypertensive patients,17 since the by cerebral angiography or, more commonly, follow- resection of this type of lesion will likely prevent ICH ing histologic study of biopsy specimens taken at the recurrence. time of surgical evacuation of the ICH. With the intro- duction of CT scanning, an increasing number of these lesions are being diagnosed by the demonstration of Brain Tumors calcium deposits in their vicinity or, more commonly, Hemorrhage into a brain tumor is a relatively rare, by the post-contrast opacification of abnormal serpigi- but well documented, cause of non-traumatic, non- nous vascular channels adjacent to an intracerebral hypertensive ICH. In series of brain tumors, ICH oc- Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
  • 4. 592 STROKE VOL 17, No 4, JULY-AUGUST 1986 curs in less than 1% of these cases, whereas underlying acute effects of the ICH leading to uncal herniation and tumors in ICH series are found in 2 to 6% of the brainstem compression or, less commonly, to the pro- cases,2021 occasionally in as many as 10% of the gression of the underlying malignant tumor.23 cases.22 These are instances of ICH in either a pre- viously unknown cerebral neoplasm or, more com- Oral Anticoagulants monly, as a complication of a known brain tumor. As a Warfarin sodium, a widely used oral anticoagulant result, ICH produces the acute onset of either a new for the prevention of venous and arterial origin embo- focal neurologic deficit, or worsening of pre-existing lism, is associated with bleeding complications in ap- focal deficits, in both instances commonly associated proximately 7-8% of patients.2*-27 Intracranial hem- with deterioration in the level of consciousness. The orrhage accounts for a small fraction of these brain tumors likely to present as ICH are largely malig- hemorrhages, amounting to only 0.5-1.5% of all nant, either primary astrocytoma (glioblastoma multi- bleeding events related to warfarin. However, these forme) or metastatic, most commonly bronchogenic intracranial hemorrhages have a generally dismal carcinoma, melanoma, choriocarcinoma, or renal-cell prognosis, thus resulting in a significant contribution carcinoma.2124 Benign brain tumors such as meningio- to the fatal complications of oral anticoagulant mas or oligodendrogliomas have rarely been reported therapy. as presenting with episodes of non-traumatic ICH. The The common intracranial sites of bleeding in orally bleeding potential of malignant tumors is thought to be anticoagulated patients are, in decreasing order of fre- related to their tendency toward spontaneous necrosis quency, the subdural space, brain parenchyma, and and to the richness and neoplastic character of their subarachnoid space. ICH in this setting represents a vasculature, as well as the biologic tendency of some condition with some distinct clinical characteristics tumors such as choriocarcinoma to invade the walls of and course, as well as high mortality and serious long- blood vessels. Metastases from this tumor are note- term sequelae in survivors. Oral anticoagulation has worthy for their tendency to become hemorrhagic in at been estimated to increase between 8-fold28 and 11- least 50% of the cases.24 fold29 the risk of ICH, as compared with non-anti- The sites of ICH relate in some degree to the type of coagulated individuals with similar risk factors for underlying tumor, since deeply-seated white matter intracranial hemorrhage. A number of possibly con- tumors such as glioblastoma multiforme will produce tributing factors to ICH have been suggested in this deep hemispheric hemorrhages, while those resulting patient population: A) Age. Several studies have indi- from metastatic tumors are more often cortico-subcor- cated a low frequency of ICH in patients younger than tical, reflecting the predilection of secondary tumors 50, and an increased risk for ICH as a function of for the superficial portions of the cerebral hemi- increasing age,29 some suggesting age 65 as a point of spheres. Most commonly, these hemorrhages originate sharp rise in the risk.28 Although other series have at the margins of the tumor, or between the tumor and failed to show a clear relationship between increasing the adjacent edematous brain parenchyma.21 Instances age and higher risk of bleeding in anticoagulated pa- in which an underlying tumor is suspected in a patient tients,2* we believe that this form of therapy should be with ICH include: (a) History of preceding chronic given to patients who are older than 70 years of age headache and/or focal neurologic deficit and/or per- only after close scrutiny of its indications and the sonality change for days or weeks prior to the onset of subject's ability to comply with its proper use and ICH, or the finding of papilledema on initial presenta- monitoring. B) Hypertension. The contribution of this tion with ICH; (b) The presence of multiple separated factor to warfarin-related ICH has also been controver- foci of ICH occurring simultaneously; (c) An area of sial, some series strongly suggesting a relationship,29 "ring-like" hemorrhage with a low-density center in while others have failed to document it.28 As a result, non-contrast CT scan; (d) An ICH that on CT scan there are no defined guidelines for the indications or appears as irregular, mottled high-density, and affect- contraindications for oral anticoagulants in hyperten- ing structures that are rarely involved in hypertensive sives. It is our policy to exclude from chronic warfarin ICH, such as the corpus callosum, which on the other therapy patients who continue to have severe and labile hand is frequently affected in glioblastoma multi- hypertension in the face of full compliance with maxi- forme; (e) A disproportionate degree of surrounding mal anti-hypertensive therapy. C) Preceding cerebral edema and mass effect associated with the hematoma; infarction has been considered by some to be important (f) Presence of post-contrast enhancement in the vi- in the pathogenesis of anticoagulant-related ICH.30 cinities of the acute high-density ICH. An angiogram However, recent large series29-3I have failed to support can be useful in demonstrating a mass lesion with the such an association: in a group of 24 patients with ICH classical "tumor blush" characteristic of highly vascu- in the course of warfarin therapy,31 only 1 bled into the lar primary or metastatic brain tumors. In many in- area of the brain that had 3 weeks before been affected stances the diagnosis is only suspected by the finding by an embolic infarct; all others with prior embolic of clinical or radiologic signs of a systemic malignan- infarcts (8 patients) had ICH in a vascular territory cy, or it is established by biopsy of the hematoma different from that involved previously. Although an cavity following its surgical evacuation. The prognosis embolic infarct can acutely become complicated by the in this form of ICH is poor, with short-term (days to formation of a hematoma in the setting of heparin or weeks) mortality in the 90% range, mostly due to the warfarin anticoagulation, this phenomenon is uncom- Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
  • 5. INTRACEREBRAL HEMORRHAGE: NON-HYPERTENSIVE CAVSES/Kase 593 mon, and appears to be limited to large size embolic noted in one series,31 and that location was also over- infarcts.32 D) Excessive prolongation of the prothrom- represented in a group of 13 cases gathered from the bin time. With very few exceptions,13 this factor is literature.30-3739 This anatomical feature of warfarin- considered to be a consistent feature in most hemorrha- related hemorrhages has no clear explanation, as it is gic complications in orally anticoagulated patients. also unclear what the actual pathogenesis of these hem- ICH is no exception to this rule: fully 80% of patients orrhages is, in terms of the size and type of the ruptured with ICH have excessively prolonged prothrombin vessels leading to the hemorrhage. It is possible that times (PT) at the onset of hemorrhage. One major these hemorrhages arerelatedto bleeding from vessels difficulty in clearly establishing this fact from the lit- different from thoseresponsiblefor hypertensive ICH. erature is the lack of agreement on what the "therapeu- Serial microscopic sections of pathologic specimens tic" PT range is: some authors recommend a prolonga- will be required to clarify these points. tion of the PT to 1 Vi to 2Vi times control,28' "• M while The overall prognosis in these ICHs is poor, with others use strictly I1/- times control.233 In studies of mortalities in the range of 65% of the cases.29'3I This warfarin therapy for prevention of venous thromboem- high mortality correlates with generally large size he- bolism, there is evidence that a "low-dose" schedule of matomas, probably reflecting the slow but eventually warfarin (enough to prolong the PT to 1VA control) is massive extravasation of blood into the parenchyma as associated with equal protection, but significantly few- a result of the drug-induced coagulation defect. De- er bleeding complications, than a "conventional" spite the routine use of vitamin K and fresh frozen schedule with PT prolonged to 1 Vi to 2 times control.36 plasma for the rapidreversalof the coagulation defect, Similar comparisons of different schedules of oral anti- neurologic deterioration and fatal outcome is the ex- coagulation are not available for the prevention of arte- pected course in two-thirds of the cases. rial thromboembolism. However, extrapolation from the venous thromboembolism data suggest that it is Use of Amphetamines and Other prudent to recommend adherence to "conservative" Sympathomimetic Drugs levels of warfarin anticoagulation, in the range of 1 Vi times control, for the prevention of bleeding complica- A number of examples of ICH secondary to the use tions. E) Duration of anticoagulant treatment. This and abuse of amphetamines and related drugs have factor has not shown a clear association with risk of been documented. The most commonly implicated ICH, since in some series the duration of therapy has preparation has been methamphetamine by the intrave- most often (in 65% of the cases) exceeded 1 year,29 nous route,40 but examples of ICH following its intra- while in others as many as 70% of the events occurred nasal and oral use are also in record. Less frequently, within the first year of treatment.31 In a group of 12 the responsible substances have been amphetamine cases gathered from several reports, the cases were and pseudoephedrine. ICH has generally occurred evenly distributed below and above 1 year of therapy shortly after use of the drug, within minutes to a few when the ICH occurred.3037-39 F) Head trauma does hours after exposure, and the affected individuals have not appear to play a role in ICH in the setting of oral been in general chronic users, although occasional ex- anticoagulation: only 4 of 24 patients (16%) had a amples have followed alleged first-time use. The ma- preceding history of trauma in a series of anticoagu- jority of the hematomas have been located in the sub- lant-related ICH.31 In all 4 instances the traumatic epi- cortical white matter of the cerebral hemispheres, only sode was considered mild in nature, and was not asso- occasional ones occurring at the level of the basal ciated with loss of consciousness. ganglia.4142 An association with transiently elevated blood pres- The clinical presentation of anticoagulant-related sure has been noted in approximately 50% of the cases, ICH has some distinctive features. A gradual and slow and thisrepresentsa likely etiologic mechanism. How- progression of the focal signs was recorded in 58% of ever, angiographic changes suggestive of vasculitis the cases in one series, and one-half of these pro- ("arteritis") have also been documented, raising the gressed over exceedingly long periods of time, of 24, possibility of a drug-induced angiopathy as the etiolo- 48, and even 72 hours.31 In some instances, this slowly gic factor.43 This view is further supported by the re- progressive course could be correlated with CT-detect- ported disappearance of such angiographic changes ed increase in size of the ICH. This feature contrasts following drug discontinuation or the use of steroids. with the usual course of hypertensive ICH, in which This angiopathy, also called "speed arteritis", is char- such a protracted initial course is rarely observed, and acterized angiographically by multiple focal areas of coincident enlargement of the hematoma by CT occurs stenosis or constriction of medium-size intracranial exceptionally following admission (observed in only 2 arteries. Pathologic examination of these vessels has of a personal consecutive series of 100 cases of ICH). shown a necrotizing angiitis similar to periarteritis no- This extended initial course suggests a process of slow dosa characterized by fibrinoid degeneration and ne- bleeding into the parenchyma, different from the usu- crosis of the media and intima of medium-size and ally catastrophic course in patients with hypertensive small arteries and arterioles, associated with variable ICH. An additional feature in anticoagulant-related degrees of inflammatory leukocytic infiltration of the hemorrhages has been an apparent difference in their vessel walls. At a later, reparative phase of the angiop- topographic distribution, as compared with hyperten- athy, collagen replacement of muscular and elastic sive ICH: a relative predilection for the cerebellum was tissue can follow, at times resulting in the formation of Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
  • 6. 594 STROKE VOL 17, No 4, JULY-AUGUST 1986 aneurysmal dilatations of the arterial wall.43 These vas- 6. Okazaki H, Reagan TJ, Campbell RJ: Clinicopathologic studies of cular changes are considered to be secondary to either primary cerebral amyloid angiopathy. Mayo Clin Proc 54: 22-31, 1979 a direct "toxic" effect of the drug or a hypersensitivity 7. Vinters HV, Gilbert JJ: Cerebral amyloid angiopathy: Incidence reaction to the drug or its vehicle. In a few isolated and complications in the aging brain II. The distribution of amyloid instances, angiography has revealed a coincidental vascular changes. Stroke 14: 924-928, 1983 AVM or aneurysm as the source of hemorrhage, which 8. Gilbert JJ, Vinters HV: Cerebral amyloid angiopathy: Incidence has been parenchymatous or subarachnoid, respective- and complications in the aging brain I. Cerebral hemorrhage. Stroke 14: 915-923, 1983 ly.44' 45 In these instances, the apparent role of the drug 9. Gudmundsson G, Hallgrimsson J, Jonasson TA, Bjarnason O: has been that of the precipitant rather than the actual Hereditary cerebral haemorrhage with amyloidosis. Brain 95: cause of the hemorrhage. 387^04, 1972 The usual therapy for this variety of ICH has been 10. Wattendorff AR, Bots GTAM, Went LN, Endtz LJ: Familial cere- bral amyloid angiopathy presenting as recurrent cerebral haemor- the use of high-dose steroids, occasionally accom- rhage. J Neurol Sci 55: 121-135, 1982 panied by immunosuppressant drugs (cyclophospha- 11. Grugg A, Jensson O, Gudmundsson G, Amason A, Lofberg H, mide). The clinical picture has followed the expected Malm J: Abnormal metabolism of y-trace alkaline microprotein: course of slow resolution of the intracerebral hemato- The basic defect in hereditary cerebral hemorrhage with amyloido- sis. New Engl J Med 311: 1547-1549, 1984 ma, and follow-up angiograms have often shown an 12. Kalyan-Raman UP, Kalyan-Raman K: Cerebral amyloid angiop- improvement or disappearance of the signs of vasculi- athy causing intracranial hemorrhage. Ann Neurol 16: 321-329, tis, attesting to its reversible character. 1984 Phenylpropanolamine, a structural analog of am- 13. Tomonaga M: Cerebral amyloid angiopathy in the elderly. J Amer phetamine contained in over-the-counter appetite con- Geriatr Soc 29: 151-157, 1981 14. Finelli PF, Kessimian N, Bernstein PW: Cerebral amyloid angiop- trol and decongestant preparations, has been associat- athy manifesting as recurrent intracerebral hemorrhage. Arch ed with ICH in previously healthy individuals.46-w The Neurol 41: 330-333, 1984 hematomas have occasionally been multiple and si- 15. Drury I, Whisnant JP, Garraway WM: Primary intracerebral hem- multaneous,47 and a "vasculitic" picture like that seen orrhage: Impact of CT on incidence. Neurology 34: 653-657, 1984 16. Crawford JV, Russell DS: Cryptic arteriovenous and venous ham- in amphetamine-related hemorrhages has also been artomas of the brain. J Neurol Neurosurg Psychiat 19: 1-11, 1956 documented. **• ** 17. Steiger HJ, Tew JM: Hemorrhage and epilepsy in cryptic cerebro- Illicit drugs have occasionally been associated with vascular malformations. Arch Neurol 41: 722-724, 1984 episodes of ICH closely following their use. These 18. Becker DH, Townsend JJ, Kramer RA, Newton TH: Occult cere- include cocaine,49 and the combination Talwin-pyri- brovascular malformations. A series of 18 histologically verified cases with negative angiography. Brain 102: 249—287, 1979 benzamine ("T's and blues").30 These drugs have at 19. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous times resulted in the production of cerebral infarction System, Fourth edition, Williams and Wilkins Co., Baltimore, pp instead of ICH, and both lesions are thought to be the 116-145, 1977 result of an angiopathy due to the drug or some of its 20. Russell DS: The pathology of spontaneous intracTanial haemor- rhages. Proc Roy Soc Med 47: 689-693, 1954 vehicles. 21. Little JR, Dial B, Bellanger G, Carpenter S: Brain hemorrhage In conclusion, this review of non-hypertensive from intracranial tumor. Stroke 10: 283-288, 1979 causes of ICH suggests that these various pathological 22. Scott M: Spontaneous intracerebral hematoma caused by cerebral entities account for a significant number of cases of neoplasms. Report of eight verified cases. J Neurosurg 42: ICH. It is possible that theirrelativecontribution to the 338-342, 1975 23. Mandybur TI: Intracranial hemorrhage caused by metastatic tu- total group of ICH cases will even increase in the mors. Neurology 27: 650-655, 1977 future, as the frequency of the hypertensive form of 24. Gildersleve N, Koo AH, McDonald CJ: Metastatic tumor present- ICH is likely to continue to decline, reflecting im- ing as intracerebral hemorrhage. Radiology 124: 109-112, 1977 proved control of hypertension in the population at 25. Bitoh S, Hasegawa H, Ohtsuki H, Obashi J, Fujiwara M, Sakurai M: Cerebral neoplasms initially presenting with massive intracere- risk. It is hoped that increased awareness, as well as bral hemorrhage. Surg Neurol 22: 57-62, 1984 improved diagnostic methods, willresultin the clinical 26. Coon WW, Willis PW: Hemorrhagic complications of anticoagu- diagnosis of these conditions, which are currently for lant therapy. Arch Int Med 133: 386-392, 1974 the most part diagnosed only pathologically. This im- 27. Forfar JC: A 7-year analysis of haemorrhage in patients on long- provement in diagnosis is likely to provide a better term anticoagulant treatment. Brit Heart J 42: 128-132, 1979 28. Furlan AJ, Whisnant JP, Elveback LR: The decreasing incidence of estimate of their true frequency in the ICH population. primary intracerebral hemorrhage: A population study. Ann Neurol 5: 367-373, 1979 References 29. Wintzen AR, de Jonge H, Loeliger EA, Bots GTAM: The risk of 1. Mohr JP, Caplan LR, Melski JW, et al: The Harvard Cooperative intracerebral hemorrhage during oral anticoagulant treatment: A Stroke Registry: A prospective registry. Neurology 28: 754-762, population study. Ann Neurol 16: 553-558, 1984 1978 30. Lieberman A, Hass WK, Pinto R, et al: IntracTanial hemorrhage 2. Mohr JP, Kase CS, Adams RD: Cerebrovascular Disorders. In: and infarction in anticoagulated patients with prosthetic heart Harrison's Principles of Internal Medicine, 10th edition, RG Pe- valves. Stroke 9: 18-24, 1978 tersdorf et al (Eds), Chapter 356, pp 2028-2060. McGraw-Hill, 31. Kase CS, Robinson RK, Stein RW et al: Anticoagulant-related New York, 1983 intracerebral hemorrhage. Neurology 35: 943-948, 1985 3. Fisher CM: Pathological observations in hypertensive cerebral 32. Hart RG, Lockwood KI, Hakim AM et al: Immediate anticoagula- hemorrhage. J Neuropath Exper Neurol 30: 536-550, 1971 tion of embolic stroke: Brain hemorrhage and management options. 4. Kase CS, Williams JP, Wyatt DA, Mohr JP: Lobar intracerebral Stroke 15: 779-789, 1984 hematomas: Clinical and CT analysis of 22 cases. Neurology 32: 33. Miale JB: Laboratory Medicine: Hematology, 5th ed, chap 17, p. 1146-1150, 1982 959. CV Mosby, St. Louis, 1977 5. RopperAH, Davis KR: Lobar cerebral hemorrhages: Acute clinical 34. Braunwald E: Heart Disease, 2nd ed, chap 32, p. 1087. WB syndromes in 26 cases. Ann Neurol 8: 141-147, 1980 Saunders, Philadelphia, 1984 Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012
  • 7. THROMBOLYTIC THERAPY IN STROKE/^/ Zoppo et al 595 35. Wessler S, Gitel SN: Warfarin: From bedside to bench. New Engl J 43. Citron BP, Halpern M, McCarron M, et al: Necrotizing angiitis Med 311: 645-652, 1984 associated with drug abuse. New Engl J Med 283: 1003-1011, 36. HullR, HirshJ, Jay R.etah Different intensities of oral anticoagu- 1970 lant therapy in the treatment of proximal-vein thrombosis. New 44. Lukes SA: Intracerebral hemorrhage from an arteriovenous malfor- Engl J Med 307: 1676-1681, 1982 mation after amphetamine injection. Arch Neurol 40: 60—61, 1983 37. Barron KD, Fergusson G: Intracranial hemorrhage as a complica- 45. Maticlc H, Anderson D, Brumlik J: Cerebral vasculitis associated tion of anticoagulant therapy. Neurology 9: 447-455, 1959 with oral amphetamine overdose. Arch Neurol 40: 253-254, 1983 46. Fallis RJ, Fisher M: Cerebral vasculitis and hemorrhage associated 38. Iizuka J: Intracranial and inlraspinal haematomas associated with with phenylpropanolamine. Neurology 35: 405—407, 1985 anticoagulant therapy. Neurochirurgia 1: 15-25, 1972 47. Kikta DG, Devereaux MW, Chandar K: Intracranial hemorrhages 39. Snyder M, Renaudin J: Intracranial hemorrhage associated with due to phenylpropanolamine. Stroke 16: 510-512, 1985 anticoagulation therapy. Surg Neurol 7: 31-34, 1977 48. Stoessl AJ, Young GB, Feasby TE: Intracerebral haemorrhage and 40. Delaney P, Estes M: Intracranial hemorrhage with amphetamine angiographic beading following ingestion of catecholaminergics. use. Neurology 30: 1125-1128, 1980 Stroke 16: 734-736, 1985 41. Harrington H, Heller HA, Dawson D, Caplan L, Rumbaugh C: 49. Caplan LR, Hier DB, Banks G: Stroke and drug abuse. Current Intracerebral hemorrhage and oral amphetamine. Arch Neurol 40: Concepts of Cerebrovascular Disease/Stroke 17: 9-14, 1982 503-507, 1983 50. Caplan LR, Thomas C, Banks G: Central nervous system compli- 42. Salanova V, Taubner R: Intracerebral haemorrhage and vasculitis cations of addiction to "T's and blues". Neurology 32: 623-628, secondary to amphetamine use. Postgrad Med J 60:429-430, 1984 1982 Thrombolytic Therapy in Stroke: Possibilities and Hazards GREGORY J. DEL ZOPPO, M.D., HERMANN ZEUMER, M.D.,* AND LAURENCE A. HARKER, M.D. AGENTS WHICH MEDIATE THE dissolution of patients with various thrombolytic agents, and to thrombi are receiving increasingly wide therapeutic weigh the relative risk of intracerebral hemorrhage in application. Urokinase or streptokinase have been em- patients treated with fibrinolytic agents for stroke and ployed in the treatment of acute thrombosis of coro- for other thrombotic disorders. nary1"23 and selected peripheral arteries,15' 23~34 traumat- ic internal carotid artery occlusion,35 as well as of Mechanism of Thrombolysis pulmonary embolism36"39 and peripheral deep venous Arterial thrombosis and thrombus extension involve thrombosis.1340"39 to varying degrees the processes of endothelial injury, The demonstration that acute stroke is typically an platelet aggregation and release, and thrombin genera- atherothrombotic or thromboembolic process60"76 pro- tion. Thrombin-mediated fibrinogen cleavage results vides a theoretical basis for the use of thrombolytic in fibrin formation which is required for thrombus sta- therapy in the treatment of acute stroke. However, bilization.80 Thrombin-mediated fibrin formation oc- because of the possibility that intracerebral hemor- curs in direct relation to platelet activation by several rhage may develop during thrombolytic therapy, use of mechanisms. Platelets promote activation of the early such agents in stroke treatment has generally been con- stages of intrinsic coagulation by a process that in- traindicated. Nevertheless, limited recent experience volves a factor XI receptor and high molecular weight indicates that careful infusion of thrombolytic agents kininogen.81 Also, factors V and VHI interact with may lead to thrombus dissolution and clinical improve- platelet membrane phospholipids to facilitate the acti- ment in selected patients presenting with acute vation of factor X to Xa and the conversion of pro- stroke.77"79 thrombin to thrombin.82 Platelet-bound thrombin- It is the purpose of this discussion to review the modified factor V (factor Va) serves as a high affinity molecular basis for the thrombolytic state, clinical platelet receptor for factor Xa.83 Consequently, the rate experience with systemic and local treatment of stroke of thrombin generation is accelerated 103 fold, provid- ing a potent positive feedback mechanism for initiation From The Roon Research Center for Cardiovascular Disease and of thrombin formation on the platelet surface, fibrin Thrombosis, Department of Basic and Clinical Research, Scripps Clime network formation in the thrombus, and indirectly, and Research Foundation, 10666 North Torrey Pines Road, La Jolla, fibrinolysis. California U.S.A. 92037, and from the Abteilung: Neurologie/Neurora- Thrombus dissolution is, in large part, mediated by diologie, Rheinische — Westphalische Technische Hochschule, Aa- chen, Pauwelsstrasse, D5100, Aachen, Federal Republic of Germany.* fibrinolysis localized within the thrombus.84"86 Fibrin This work was supported in part by research grant HL 31950 from the (and fibrinogen) degradation is catalyzed by plasmin, National institutes of Health. the product of plasminogen activation.87 In the consoli- Address correspondence to: Gregory J. Del Zoppo, M.D., Roon dating thrombus plasminogen binds to fibrin and to Research Center for Cardiovascular Disease and Thrombosis, Depart- platelets, allowing local release of plasmin within the ment of Basic and Clinical Research, Scripps Clinic and Research Foundation, 10666 North Torrey Pines Road, La Jolla, California thrombus. The circulating plasminogen activators, tis- U.S.A. 92037. sue plasminogen activator (tPA) and single chain uro- Received February 6, 1986; revision #1 accepted May 12, 1986. kinase plasminogen activator (scuPA), catalyze plas- Downloaded from http://stroke.ahajournals.org/ by guest on October 15, 2012